In Axogen Inc (AXGN) was decreased the holdings held by Opaleye Management Inc. The decrease is 16.03% according to 2018Q2 SEC filling. By selling 275,000 shares Opaleye Management Inc made the stock sank with 27.73%. The hedge fund is holding 1.44 million shares, compared to the 1.72M from the previous quarter. And the announced value of the health care company is $72.36 million for the 2018Q2. $1.41B is the MC of Axogen Inc. AXGN touched $36.38 during the last trading session after $1.27 change.AxoGen, Inc. has volume of 258,481 shares. Since November 10, 2017 AXGN has risen 96.73% and is uptrending. The stock outperformed the S&P500 by 81.11%.
Opaleye Management Inc has risen its stake in and also increased its holding in by shares in the quarter, for a total of shares.
More recent AxoGen, Inc. (NASDAQ:AXGN) news were posted by Nasdaq.com, Seekingalpha.com and Globenewswire.com. The first one has “New Research: Key Drivers of Growth for AxoGen, Spirit Realty Capital, elf Beauty, Minerva Neurosciences, Par Pacific …” as a title and was posted on November 09, 2018. The next is “Is AxoGen A Buy On The Dip?” on October 15, 2018. And last was posted on October 29, 2018, called “AxoGen, Inc. Reports 2018 Third Quarter Financial Results”.
AxoGen, Inc. (NASDAQ:AXGN) Ratings Coverage
In total 2 analysts cover AxoGen (NASDAQ:AXGN). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. (NASDAQ:AXGN) has 100% bullish analysts. 2 are the (NASDAQ:AXGN)’s ratings reports on Nov 10, 2018 according to StockzIntelligence Inc. On Tuesday, October 30 the stock has “Overweight” rating by Cantor Fitzgerald. On Tuesday, June 26 the rating was maintained by Leerink Swann with “Buy”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.